Dexlansoprazole DDR Pellets
Dexlansoprazole DDR Pellets 17%, 20%, 22.5%, 23% – Suitable for Capsules (Dose: 30 mg, 60 mg)
Dexlansoprazole is a proton pump inhibitor (PPI) based on unique dual delayed release technology. The active ingredient is released in two phases at different pH values, resulting in two peak plasma concentrations and prolonged acid suppression.
- Development services available for different formulations, dosages, or strengths.
- Complete technical package available for registrations in all regulated/semi-regulated markets.
- Products protected by ongoing patents are not offered.
Additional Information
| Percentage | 17%, 20%, 22.5%, 23% |
|---|---|
| Release Type | Dual Delayed Release |
| Documentation Available: | Technical Package |
| Forms of PFI | Pellets/Micro pellets (for capsules) |
| Target Formulations | Capsules |
